Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
These nutrients can help keep you fuller for longer something that's even more important once semaglutide isn't helping with appetite control anymore
MCAS, or mast cell activation syndrome, is a condition where your mast cells overreact, causing symptoms like food reactions, brain fog, skin flushing, fatigue, digestive issues, and anxiety
This low molecular weight allows MCP to easily pass through the intestinal barrier and enter the systemic circulation
Heres what that looks like in practice